Comparator: modified process hepatitis B vaccine

BIOLOGICAL3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Hepatitis BHepatitis B Virus InfectionHepatocellular Carcinoma

Phase 2

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

CompletedNCT00322361

Merck Sharp & Dohme LLCHepatitis B, Hepatocellular Carcinoma

Start: 2006-05-31End: 2007-07-31Updated: 2017-03-16

Phase 3

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

CompletedNCT00393523

Merck Sharp & Dohme LLCHepatitis B

Start: 2006-09-30End: 2008-06-30Updated: 2017-04-12

Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

CompletedNCT00440297

Merck Sharp & Dohme LLCHepatitis B Virus Infection

Start: 2006-12-31End: 2008-05-31Updated: 2017-04-13